TNFRSF1A and diabetic kidney disease: Subsequently, several companion studies showed that the inflammation pathway is associated with DKD, with the tumor necrosis factor receptors 1/2 (TNFR1/2) and glycated hemoglobin A1c being remarkable biomarkers for the progression of advanced DKD [11, 12, 13].